IL10 and inflammatory bowel disease: Although the IL-10 fusion protein and an invasive L. lactis strain carrying the IL-10 plasmid both alleviated colitis in a range of colitis models, including IL-10-deficient mice [131,132], IBD patients can have raised levels of IL-10 in serum [134] and may not benefit from IL-10 therapy [129,135].